Abstract 2111P
Background
Psychometric assessment tools are widely available but underutilized in daily oncology practice. The aim of this study was to evaluate the role of multiple psychometric scales in identifying cancer patients in distress who need Psycho-Oncology management.
Methods
Colorectal cancer patients were prospectively asked to complete a survey including 3 psychometric scales (GAD-7, PHQ-9, PC-PTSD-5). Those scoring high on at least one scale (GAD-7 score ≥ 10, PHQ-9 score ≥ 10, PC-PTSD-5 score ≥ 4) were offered referral to the Psycho-Oncology service. Those accepting the referral were further triaged by members of this service via a standardized semi-structured interview. Patients were divided into three groups: those accepted by the Psycho-Oncology service, those declined the referral and those discharged from the service with no need for further intervention. Outcomes were compared with the analysis of variance test (ANOVA).
Results
Fifty-four patients (30 females) of median age 60 years (range 36-81) were prospectively evaluated. 20 patients (37%) reported their cancer was under control, 15 (28%) believed they had progressive disease, while 19 (35%) were uncertain. Approximately half patients (26; 48%) referred a prior history of a mental condition. The mean (±SE) scores for each psychometric scale were 10.96 (± 0.78), 12.79 (± 0.82), and 1.07 (± 0.21), respectively for GAD-7, PHQ-9, PC-PTSD-5. Thirty-four patients (63%) scored high on GAD-7, 40 (74%) on PHQ-9 and 8 (15%) on PC-PTSD-5. Almost half of the patients declined a referral (25, 46%), 22 (41%) were assessed by a Psycho-Oncologist and managed accordingly and 7 (13%) were discharged after the initial tirage. There was no statistically significant difference in the mean psychometric scores between the three identified groups (p<0.05).
Conclusions
Psychometric scales are useful screening tools to identify distress but cannot differentiate between general distress and psychological/psychiatric symptoms requiring specialist intervention. Psychometric scales should be used in conjunction with semi-structured interviews. The ‘screen and triage’ model should be further investigated as part of an integrated care model, to signpost cancer patients to appropriate support services.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Servier.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2085P - Buprenorphine use and cancer outcomes
Presenter: Nosayaba Osazuwa-Peters
Session: Poster session 06
2086P - Management of opioids use disorder in cancer survivors
Presenter: Khalida Berkane
Session: Poster session 06
2087P - Impact of cancer pain on quality of life and financial well-being: A cross-sectional study on symptom management
Presenter: Raffaele Giusti
Session: Poster session 06
2088P - Management of cancer treatment-induced bone loss in patients with breast and hormone sensitive prostate cancer: AIOM survey among Italian oncologists
Presenter: Anna Amela Valsecchi
Session: Poster session 06
2090P - Management of trastuzumab deruxtecan-related nausea and vomiting in real-world practice
Presenter: Luca Licata
Session: Poster session 06
2091P - Dermocosmetics in management of cancer-related skin toxicities: International expert consensus highlighting the key role of oncology nurses
Presenter: Pascale Dielenseger
Session: Poster session 06
2092P - Bone loss in premenopausal Algerian women treated with chemotherapy for early-stage of breast cancer: Evaluation by DXA and identification of associated risk factors
Presenter: MACHEROUM Fatma zohra
Session: Poster session 06
2093P - Bioelectrical Impedance phase angle and obesity as a prognostic indicator in metastatic gastric cancer patients receiving second-line chemotherapy
Presenter: SangUk Han
Session: Poster session 06
2094P - A multicenter phase II trial of the triplet antiemetic therapy with palonosetron, aprepitant and olanzapine for highly emetogenic chemotherapy in breast cancer
Presenter: Shinya Takada
Session: Poster session 06